First AD

Second AD

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Oncology Business Management

 Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Updates in HER2+ Metastatic Breast Cancer: HER2CLIMB

OncLive News Network®

Personal Experience With the HER2CLIMB Regimen in mBC

Relapsed/Refractory HER2+ mBC: Evolving Treatment Landscape

Exciting Results From HER2CLIMB in HER2+ mBC

HER2CLIMB: Implications for Brain Metastases in HER2+ mBC

HER2+ mBC: Safety and Tolerability in HER2CLIMB

HER2CLIMB: Sequencing in Metastatic Breast Cancer

Relapsed/Refractory HER2+ mBC: Future Treatment Landscape